The VA is buying a new type of imaging agent for prostate cancer

The Cincinnati VA Medical Center just awarded a contract to buy a radiopharmaceutical called Pylarify. This agent helps doctors see prostate cancer more clearly on PET scans, even when it has spread.

For years, doctors struggled to find prostate cancer once it left the prostate gland. Standard imaging often missed small tumors. Pylarify makes these hidden tumors visible, which means doctors can better plan treatments and track how well they are working. This purchase means more veterans will get access to this advanced diagnostic tool.